APA (7th ed.) Citation

Nannini, S., Guisier, F., Curcio, H., Ricordel, C., Demontrond, P., Abdallahoui, S., . . . Schott, R. (2024). Outcomes of Patients with Non-Small Cell Lung Cancer and Brain Metastases Treated with the Upfront Single Agent Pembrolizumab: A Retrospective and Multicentric Study of the ESCKEYP GFPC Cohort. Current oncology (Toronto), 31(3), 1656-1666. https://doi.org/10.3390/curroncol31030126

Chicago Style (17th ed.) Citation

Nannini, Simon, et al. "Outcomes of Patients with Non-Small Cell Lung Cancer and Brain Metastases Treated with the Upfront Single Agent Pembrolizumab: A Retrospective and Multicentric Study of the ESCKEYP GFPC Cohort." Current Oncology (Toronto) 31, no. 3 (2024): 1656-1666. https://doi.org/10.3390/curroncol31030126.

MLA (9th ed.) Citation

Nannini, Simon, et al. "Outcomes of Patients with Non-Small Cell Lung Cancer and Brain Metastases Treated with the Upfront Single Agent Pembrolizumab: A Retrospective and Multicentric Study of the ESCKEYP GFPC Cohort." Current Oncology (Toronto), vol. 31, no. 3, 2024, pp. 1656-1666, https://doi.org/10.3390/curroncol31030126.